WG
HTGM

Winton Group’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Winton Group’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,056
Closed -$63K – 1572
2020
Q3 		$63K Sell
1,056
-115
-10% -$10.3K ﹤0.01% 1436
2020
Q2 		$152K Buy
1,171
+795
+211% +$70.2K ﹤0.01% 1382
2020
Q1 		$22K Buy
376
+240
+176% +$23.5K ﹤0.01% 1368
2019
Q4 		$17K Buy
+136
New +$18.4K ﹤0.01% 1513

Other funds holding HTGM

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Winton Group's HTGM Position: Q4 2020 in Review

Winton Group sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2020, closing a stake of 1,056 shares — an estimated $63K sold.

Winton Group first reported a position in HTGM in Q4 2019 and held it in 4 quarters. The position peaked at $152K in Q2 2020. 23 funds tracked by Wall St. Rank hold HTGM as of Q4 2020.

  • Winton Group reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Winton Group sold 1,056 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2020, an estimated $63K.
  • Winton Group first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Winton Group's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $152K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.